The Chemours Co
(NYSE:CC)
$28.90
0.11[0.38%]
Last update: 4:20PM (Delayed 15-Minutes)
Get Real Time Here
$28.90
0[0.00%]
After-Hours
Open28.850Close28.900
Vol / Avg.551.743K / 1.270MMkt Cap4.290B
Day Range28.715 - 29.62052 Wk Range22.880 - 39.050

Chemours Stock (NYSE:CC), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$47.00

Lowest Price Target1

$25.00

Consensus Price Target1

$30.33

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
60501

Analyst Firms Making Recommendations1

  • RBC Capital
  • JP Morgan
  • Goldman Sachs
  • BMO Capital
  • Morgan Stanley

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Chemours

Upgrades (6)

Downgrades (4)

Initiations (4)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
12/01/2023CCBuy Now
Chemours
$28.9038.41%RBC Capital
Arun Viswanathan
$28 → $40UpgradeSector Perform → OutperformGet Alert
11/07/2023CCBuy Now
Chemours
$28.90-10.03%JP Morgan
Jeffrey Zekauskas
$38 → $26MaintainsNeutralGet Alert
10/31/2023CCBuy Now
Chemours
$28.903.81%Goldman Sachs
Duffy Fischer
$35 → $30MaintainsNeutralGet Alert
10/30/2023CCBuy Now
Chemours
$28.90-3.11%RBC Capital
Arun Viswanathan
$30 → $28MaintainsSector PerformGet Alert
10/30/2023CCBuy Now
Chemours
$28.9034.95%BMO Capital
John McNulty
$45 → $39MaintainsOutperformGet Alert
10/30/2023CCBuy Now
Chemours
$28.90-3.11%Morgan Stanley
Vincent Andrews
$33 → $28MaintainsEqual-WeightGet Alert
10/30/2023CCBuy Now
Chemours
$28.90-3.11%Barclays
Michael Leithead
$31 → $28MaintainsEqual-WeightGet Alert
10/04/2023CCBuy Now
Chemours
$28.907.27%Barclays
Michael Leithead
$40 → $31MaintainsEqual-WeightGet Alert
08/02/2023CCBuy Now
Chemours
$28.9083.39%BMO Capital
John McNulty
$64 → $53MaintainsOutperformGet Alert
08/01/2023CCBuy Now
Chemours
$28.9014.19%Morgan Stanley
Vincent Andrews
$33 → $33ReiteratesEqual-Weight → Equal-WeightGet Alert
07/31/2023CCBuy Now
Chemours
$28.9038.41%RBC Capital
Arun Viswanathan
$37 → $40MaintainsSector PerformGet Alert
07/19/2023CCBuy Now
Chemours
$28.9014.19%Morgan Stanley
Vincent Andrews
$33 → $33ReiteratesEqual-Weight → Equal-WeightGet Alert
07/11/2023CCBuy Now
Chemours
$28.9038.41%Barclays
Michael Leithead
$38 → $40MaintainsEqual-WeightGet Alert
06/22/2023CCBuy Now
Chemours
$28.9028.03%B of A Securities
Matthew DeYoe
$41 → $37DowngradeBuy → NeutralGet Alert
06/13/2023CCBuy Now
Chemours
$28.9048.79%UBS
Joshua Spector
$41 → $43MaintainsBuyGet Alert
06/09/2023CCBuy Now
Chemours
$28.9028.03%RBC Capital
Arun Viswanathan
$36 → $37MaintainsSector PerformGet Alert
06/05/2023CCBuy Now
Chemours
$28.90121.45%BMO Capital
John McNulty
$54 → $64MaintainsOutperformGet Alert
05/31/2023CCBuy Now
Chemours
$28.903.81%JP Morgan
Jeffrey Zekauskas
$35 → $30MaintainsNeutralGet Alert
05/01/2023CCBuy Now
Chemours
$28.9024.57%RBC Capital
Arun Viswanathan
$35 → $36MaintainsSector PerformGet Alert
Q

What is the target price for Chemours (CC)?

A

The latest price target for Chemours (NYSE: CC) was reported by RBC Capital on December 1, 2023. The analyst firm set a price target for $40.00 expecting CC to rise to within 12 months (a possible 38.41% upside). 30 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Chemours (CC)?

A

The latest analyst rating for Chemours (NYSE: CC) was provided by RBC Capital, and Chemours upgraded their outperform rating.

Q

When is the next analyst rating going to be posted or updated for Chemours (CC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chemours, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chemours was filed on December 1, 2023 so you should expect the next rating to be made available sometime around December 1, 2024.

Q

Is the Analyst Rating Chemours (CC) correct?

A

While ratings are subjective and will change, the latest Chemours (CC) rating was a upgraded with a price target of $28.00 to $40.00. The current price Chemours (CC) is trading at is $28.90, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.